FDA Inspection 1338282 — Baccinex Sa

Baccinex Sa — FEI 3007272813

The FDA completed an inspection of Baccinex Sa on Jun 7, 2024 in Courroux. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 7, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Courroux (Switzerland)

Additional Details

Mutual Recognition Agreement (MRA)